Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 25 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2006Enantioselective assay for the determination of perhexiline enantiomers in human plasma by liquid chromatographyDavies, B.; Herbert, M.; Culbert, J.; Pyke, S.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2006Determination of the 4-monohydroxy metabolites of perhexiline in human plasma, urine and liver microsomes by liquid chromatographyDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2003Relationship between CYP2D6 genotype and plasma OH-perhexiline/perhexiline concentration ratio in angina patients.Sallustio, B.; Davies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.
2004A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysisJames, H.; Coller, J.; Gillis, D.; Bahnisch, J.; Sallustio, B.; Somogyi, A.
2007Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadonColler, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
2008TGFβ2 and TβRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cellsBuck, M.; Coller, J.; Murdter, T.; Eichelbaum, M.; Knabbe, C.
2008Response to "No influence of ABCB1 haplotypes on methadone dosage requirement"Coller, J.; Barratt, D.; Somogyi, A.
2008Pharmacogenomics and PharmacogeneticsSomogyi, A.; Coller, J.
2009Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRMI) and opioid defendence: A meta-analysisColler, J.; Beardsley, J.; Bignold, J.; Li, Y.; Merg, F.; Sullivan, T.; Cox, T.; Somogyi, A.